Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Dalteparin Sodium

Known as: Dalteparin sodná s?l, Dalteparin Sodyum, Daltéparine sodique 
A drug used to prevent blood clots from forming or to treat blood clots that have formed in patients with cancer or other conditions. Dalteparin… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
BACKGROUND Ambulatory cancer patients at high-risk for venous thromboembolism (VTE) can be identified using a validated risk… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Annualised figures show an up to 7-fold higher incidence of vascular thromboembolism (VTE) in patients with advanced… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND Use of low-molecular-weight heparins is avoided in patients with renal insufficiency because of concerns about an… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2008
2008
BackgroundCritically ill patients with renal insufficiency are predisposed to both deep vein thrombosis (DVT) and bleeding. The… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2007
2007
BACKGROUND The risk of decreased bone mineral density (BMD) with prophylactic dose long-term low-molecular-weight heparin (LMWH… Expand
Is this relevant?
Review
2005
Review
2005
Patients with cancer have long been recognised to be at high risk of venous thromboembolism (VTE), although the condition remains… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND The treatment of patients at increased risk for arterial thromboembolism who require temporary interruption of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Background Based on the current understanding that venous thrombosis starts perioperatively, administration of just-in-time low… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Based on the current understanding that venous thrombosis starts perioperatively, administration of just-in-time low… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
The present trial was designed to comparatively investigate the pharmacokinetic profile and evaluate the apparent bioavailability… Expand
Is this relevant?